ArticleEuropean heart journal. Case reports2025
Mitral regurgitation in patients with hypertrophic cardiomyopathy: a case series.
Article in European heart journal. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Role of Cardiovascular Magnetic Resonance Imaging in Athletic Individuals-A Narrative Review.Journal of clinical medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mitral regurgitation (MR) is a frequent occurrence in hypertrophic cardiomyopathy (HCM), often explained by valvular or sub-valvular abnormalities as part of a broad HCM phenotype spectrum. Case summary: In this case series, we present two HCM cases diagnosed with systolic anterior motion of the anterior mitral valve (MV) leaflet and left ventricular outflow tract (LVOT) obstruction. Both cases had abnormal sub-valvular abnormalities that led to deterioration of LVOT obstruction and MR. The series highlights the need for close collaboration within a multidisciplinary team, with a special emphasis on the need for a personalized treatment strategy when considering septal reduction therapy and/or MV surgery. Discussion: Mitral regurgitation is linked to adverse cardiac outcomes, often contributing towards symptoms, poor functional capacity, hospitalization, and advanced therapies. Complex and interlinked biomechanical factors lead to MR, often co-existing with LVOT obstruction. Multimodality imaging with echocardiography (transthoracic and transoesophageal) and cardiac magnetic resonance imaging plays a key role in determining the aetiology of MR in HCM. This case series highlights the role of this comprehensive assessment, paving the way for a personalized treatment pathway for patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.